JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CRHM
3076
DELISTED
CRH Medical Corporation
CRHM
| $1.38M | ﹤0.01% |
+242,500
| New | +$1.57M |
2017 Q2
0 quarters
|
|
3077
First Trust STOXX European Select Dividend Income Fund
FDD
$883M
| $1.38M | ﹤0.01% |
105,167
+36,550
| +53% | +$475K |
2015 Q3
7 quarters
|
|
3078
Universal Electronics
UEIC
$71.4M
| $1.37M | ﹤0.01% |
20,461
-14,558
| -42% | -$967K |
2013 Q2
16 quarters
|
|
3079
Smith & Wesson
SWBI
$657M
| $1.36M | ﹤0.01% |
79,987
-390,537
| -83% | -$6.73M |
2015 Q4
6 quarters
|
|
3080
BioCryst Pharmaceuticals
BCRX
$2.02B
| $1.36M | ﹤0.01% |
244,613
-6,242
| -2% | -$38K |
2016 Q4
2 quarters
|
|
3081
CALL
NextEra Energy
NEE
$160B
| $1.36M | ﹤0.01% |
38,800
| – | – |
2017 Q1
1 quarter
|
|
|
CPN
3082
CALL
DELISTED
Calpine Corporation
CPN
| $1.35M | ﹤0.01% |
100,000
+4,600
| +5% | +$55.4K |
2017 Q1
1 quarter
|
|
3083
ProShares Ultra S&P500
SSO
$8.82B
| $1.35M | ﹤0.01% |
+120,800
| New | +$1.32M |
2017 Q2
0 quarters
|
|
3084
Vanguard Morningstar Large-Cap ETF
VV
$55.3B
| $1.35M | ﹤0.01% |
12,150
+1,265
| +12% | +$139K |
2013 Q2
16 quarters
|
|
3085
Ironwood Pharmaceuticals
IRWD
$597M
| $1.35M | ﹤0.01% |
85,145
-254,392
| -75% | -$3.7M |
2014 Q3
11 quarters
|
|
|
ARA
3086
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.34M | ﹤0.01% |
72,250
+68,950
| +2,089% | +$1.2M |
2016 Q2
4 quarters
|
|
3087
McGrath RentCorp
MGRC
$2.88B
| $1.34M | ﹤0.01% |
38,666
-2,077
| -5% | -$71K |
2016 Q4
2 quarters
|
|
3088
World Acceptance Corp
WRLD
$820M
| $1.34M | ﹤0.01% |
17,829
+3,833
| +27% | +$262K |
2016 Q3
3 quarters
|
|
|
ABIL
3089
DELISTED
Ability Inc
ABIL
| $1.33M | ﹤0.01% |
104,300
| – | – |
2016 Q1
5 quarters
|
|
3090
G-III Apparel Group
GIII
$1.17B
| $1.33M | ﹤0.01% |
53,339
-38,511
| -42% | -$895K |
2013 Q2
16 quarters
|
|
|
CORR
3091
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.33M | ﹤0.01% |
39,550
+17,062
| +76% | +$600K |
2016 Q2
4 quarters
|
|
|
HTZ
3092
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.32M | ﹤0.01% |
+132,365
| New | +$1.42M |
2017 Q2
0 quarters
|
|
3093
Federated Hermes
FHI
$4.21B
| $1.32M | ﹤0.01% |
46,793
-51,732
| -53% | -$1.38M |
2013 Q2
16 quarters
|
|
|
TI
3094
DELISTED
Telecom Italia
TI
| $1.32M | ﹤0.01% |
141,196
-9,910
| -7% | -$91.7K |
2013 Q4
14 quarters
|
|
3095
FS KKR Capital
FSK
$3.01B
| $1.32M | ﹤0.01% |
36,034
+32,909
| +1,053% | +$1.24M |
2017 Q1
1 quarter
|
|
3096
Oppenheimer Holdings
OPY
$1.34B
| $1.32M | ﹤0.01% |
80,459
+3,725
| +5% | +$61.4K |
2013 Q2
16 quarters
|
|
|
GIFI
3097
DELISTED
Gulf Island Fabrication
GIFI
| $1.31M | ﹤0.01% |
113,265
+12,200
| +12% | +$123K |
2014 Q2
12 quarters
|
|
|
STB
3098
DELISTED
Student Transportation Inc
STB
| $1.31M | ﹤0.01% |
+216,200
| New | +$1.28M |
2017 Q2
0 quarters
|
|
3099
PUT
Eastman Chemical
EMN
$7.46B
| $1.31M | ﹤0.01% |
15,600
-198,400
| -93% | -$16M |
2017 Q1
1 quarter
|
|
3100
iShares Global Energy ETF
IXC
$3.06B
| $1.31M | ﹤0.01% |
42,160
+8,607
| +26% | +$279K |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.